50
Participants
Start Date
February 11, 2019
Primary Completion Date
February 28, 2027
Study Completion Date
February 28, 2027
Imaging Drug FluorThanatrace (FTT)
\[18F\]FTT is an investigational radioactive PET drug used to see PARP-1 activity in tumors. This radioactive imaging drug is injected into the body to see how it goes into places where there is active breast cancer. Using an imaging scan called Positron Emission Tomography (PET/CT), the radioactive drug can be seen in the body.
University of Pennsylvania, Philadelphia
University of Pennsylvania
OTHER